🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Breast cancer is the second most common invasive malignancy and the leading...
Status
Terminated
Location
Hospital del Mar
Start Date
2022-05-11
Trial ID
NCT05385705
Treatments Being Tested
This study is designed to determine the efficacy and safety of allogeneic b...
Status
Unknown
Location
The First Affiliated Hospital, Sun Yat-sen University
Start Date
2015-10
Trial ID
NCT02561767
The purpose of this study is to compare the efficacy of CD25 monoclonal ant...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2014-09
Trial ID
NCT02241018
Treatments Being Tested
Acute graft-versus-host disease (aGVHD) is the most common life-threatening...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2020-12-15
Trial ID
NCT05021276
Treatments Being Tested
In this research study, our main goal for the ipilimumab portion of the stu...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Start Date
2019-07-10
Trial ID
NCT03912064
Treatments Being Tested
The first-line treatment of acute graft-versus-host disease with humanized ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-01
Trial ID
NCT06473909
Treatments Being Tested
This study will evaluate the safety and effectiveness of Zenapax in control...
Status
Completed
Location
National Eye Institute (NEI)
Start Date
1999-07
Trial ID
NCT00001865
Treatments Being Tested
Background: * About 80% of patients with hairy cell leukemia (HCL) have tu...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2006-05-02
Trial ID
NCT00321555
Treatments Being Tested
This is a first in human, open-label, multi-center Phase 1 / 2 study to eva...
Status
Recruiting
Location
Sylvester Comprehensive Cancer Center - Miami
Start Date
2022-04-04
Trial ID
NCT05267626
Treatments Being Tested
This study will examine the safety and effectiveness of daclizumab (also ca...
Status
Completed
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date
2002-06
Trial ID
NCT00040248
Treatments Being Tested